Please provide your email address to receive an email when new articles are posted on . KIAWAH ISLAND, S.C. — A study suggested that electrocardiogram screening should be performed in patients with ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, announced today that ...

Researchers have developed an AI tool that can help doctors predict who might develop a potentially fatal heart condition, just from an ECG. Subscribe to our newsletter for the latest sci-tech news ...

Thirty day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking science presented ...

Compared with the standard of care, an AI-based ECG model greatly reduced false positives for ST-elevation myocardial ...

Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...

(RTTNews) - Tempus AI, Inc (TEM), Wednesday announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECF-AF, which utilizes AI to detect ...

Using artificial intelligence (AI) to analyze electrocardiograms (ECG) improved detection of severe heart attacks, including ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology and nference portfolio company working in collaboration with Mayo Clinic, today announced U.S. Food and Drug ...

A dedicated centre at Queen Mary Hospital for treating heart attack patients says it will expand and start using ...